Biogen Inc. (BIIB) is in Healthcare, Drug Manufacturers - General, based in United States, listed on NasdaqGS. Market cap 32.27B USD. 52-week range 138.00 to 230.49 USD. Trailing P/E 38.8. Data as of 2026-10-09.
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar ...